UPS
BSX icon

UHLMANN PRICE SECURITIES’s Boston Scientific BSX Stock Holding History

UHLMANN PRICE SECURITIES’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,000
Closed -$215K – 196
2025
Q2 		$215K Hold
2,000
– – 0.15% 160
2025
Q1 		$202K Buy
+2,000
New +$201K 0.15% 157

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UHLMANN PRICE SECURITIES's BSX Position: Q3 2025 in Review

UHLMANN PRICE SECURITIES sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 2,000 shares — an estimated $215K sold.

UHLMANN PRICE SECURITIES first reported a position in BSX in Q1 2025 and held it in 2 quarters. The position peaked at $215K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • UHLMANN PRICE SECURITIES reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
  • UHLMANN PRICE SECURITIES sold 2,000 Boston Scientific shares in Q3 2025, an estimated $215K.
  • UHLMANN PRICE SECURITIES first reported a position in Boston Scientific in Q1 2025 and held it in 2 quarters.
  • UHLMANN PRICE SECURITIES's Boston Scientific position peaked at $215K in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on UHLMANN PRICE SECURITIES's 13F filing for Q3 2025, filed 7 Nov 2025.